NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function is a research paper published in Molecular Therapy (2022). On theSindex it has a DataRank of 0. It has been cited 69 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Cancer Society
Grant: RSG-20-036-01
Natural Science Foundation of Hunan Province
Grant: R01EY032159
Natural Science Foundation of Hunan Province
Grant: 2018JJ3742
Natural Science Foundation of Hunan Province
Grant: CX001298
Natural Science Foundation of Hunan Province
Grant: R01EY025295
National Institutes of Health
Grant: EY028106
National Institutes of Health
Grant: EY023295
National Institutes of Health
Grant: EY024932
National Institutes of Health
Grant: EY031063
National Eye Institute
Grant: P30 EY026877
NEI NIH HHS
Grant: R01 EY023295
NEI NIH HHS
Grant: R21 EY031063
NEI NIH HHS
Grant: R01 EY028106
NEI NIH HHS
Grant: R01 EY024932
Research to Prevent Blindness
Stanford University
BrightFocus Foundation
Stanford Maternal and Child Health Research Institute
Glaucoma Research Foundation
FWCI
11.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals